financetom
Business
financetom
/
Business
/
Qantas to cut up to 2,500 jobs as it outsources ground handling in Australia
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Qantas to cut up to 2,500 jobs as it outsources ground handling in Australia
Aug 25, 2020 12:34 AM

Qantas Airways Ltd said on Tuesday it planned to cut up to 2,500 jobs by outsourcing its Australian ground handling operations to lower costs as it braces for a A$10 billion ($7.17 billion) hit to revenue due to the pandemic this financial year.

The expected job cuts are on top of 6,000 across its workforce announced in June, which would take the total job losses to nearly 30 percent of its pre-pandemic staffing.

Qantas' head of domestic operations Andrew David said in a statement outsourcing the ground handling jobs would save an estimated A$100 million each year in operating costs. It would also allow the airline to avoid investing A$100 million in equipment like tugs and bag loaders over the next five years by outsourcing the work to a specialist ground handler, Gareth Evans, Chief Executive of Jetstar, Qantas' budget arm, said in the statement.

The statement did not name the firms that could be involved in the outsourcing, but major ground handlers in Australia include dnata, Swissport and Menzies Aviation.

Qantas said as part of a union agreement, it would also have to offer the opportunity for the 2,000 ground handlers at its main brand to bid for the work, though it will not have to do so at Jetstar.

The airline said it would complete its review over the next few months. Most of its ground handling employees have been stood down from work for months and are receiving government aid due to the decline in travel demand.

The Transport Workers' Union, which represents the ground handlers, did not respond immediately to a request for comment.

($1 = 1.3941 Australian dollars)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved